[F14. P complies with this paragraph if P—N.I.
(a)has participated, or is participating, in a clinical trial regulated in the United States of America by the Food and Drugs Administration of a vaccine for vaccination against coronavirus,
(b)is able, if required by an immigration officer or the operator of the relevant service on which P travels to Northern Ireland, to provide proof of such participation through the Centres for Disease Control and Prevention vaccination card, [F2and]
(c)has declared on the Passenger Locator Form that P meets the COVID-19 vaccination eligibility criteria F3... F4...
F5(d). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .]
Textual Amendments
F1Sch. 2B inserted (2.8.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 4) Regulations (Northern Ireland) 2021 (S.R. 2021/225), regs. 1(2), 4(2) (with reg. 11)
F2Word in Sch. 2B para. 4(b) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 9) Regulations (Northern Ireland) 2021 (S.R. 2021/301), regs. 1(2), 9(b)(i) (with reg. 1(3))
F3Words in Sch. 2B para. 4(c) omitted (4.10.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 7) Regulations (Northern Ireland) 2021 (S.R. 2021/278), regs. 1(2), 5(11) (with reg. 1(4))
F4Word in Sch. 2B para. 4(c) omitted (22.11.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 9) Regulations (Northern Ireland) 2021 (S.R. 2021/301), regs. 1(2), 9(b)(ii) (with reg. 1(3))
F5Sch. 2B para. 4(d) omitted (22.11.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 9) Regulations (Northern Ireland) 2021 (S.R. 2021/301), regs. 1(2), 9(b)(iii) (with reg. 1(3))